Helio.com

CHICAGO — Direct-to-patient strategies may be more effective than broad campaigns at minimizing racial and ethnic disparities in lupus clinical […]

CHICAGO — The novel, oral tyrosine kinase 2 inhibitor deucravacitinib yielded durable ACR20 response rates through week 52 in patients

The American Osteopathic Association announced it has filed a lawsuit challenging an American Board of Internal Medicine policy which limits

CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive protein in

DALLAS — Blue Zones and the American College of Lifestyle Medicine developed a certification process designed to equip physicians with

It’s been nearly 1 year since Healio Community opened its proverbial doors to health care professionals looking to connect with

Financial stability and fostering unity to combat “division and chaos” are two top priorities for new American College of Rheumatology

Physician author Kevin J. Tracey, MD, discussed his book, The Great Nerve: The New Science of the Vagus Nerve and

CHICAGO — Cognitive errors, which can sometimes stem from “data overload,” can lead to misdiagnoses of complex rheumatic and autoimmune

CHICAGO — A previous diagnosis of a mental health disorder may predict neuropsychiatric complications in children with systemic lupus erythematosus,

CHICAGO — Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors had a lower risk for rheumatic disease vs.

CHICAGO — The novel B cell-targeting therapy ianalumab demonstrated improvement over placebo in key Sjögren’s disease parameters, according to data

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights how the lupus armamentarium

CHICAGO — Pregnant individuals with rheumatic diseases who were exposed to disease-modifying antirheumatic drugs did not experience severe morbidity, according

CHICAGO — Elevated levels of air pollution, specifically PM 2.5, may increase rheumatoid arthritis incidence rates and flares, according to

Health care providers can use social media to fight misinformation and rebuild trust in medicine, according to Dr. Mike.Mikhail O.

Among patients with rheumatoid arthritis, those with higher levels of three adipokines demonstrated an increased risk for fracture, according to

SAN ANTONIO — The herbal remedy known as kratom, which comes from a tree that grows primarily in Southeast Asia,

CHICAGO — De novo autoimmune diseases, including myositis, vasculitis and lupus, may occur after chimeric antigen receptor T-cell therapy for

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded it

The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and

A cognitive behavioral therapy program delivered by smartphone app improved the mental health and quality of life of people with

SAN ANTONIO — Managing pediatric vasculitis demands special considerations in the clinic, in school and at home, according to a

CHICAGO — Pancytopenia and thrombocytopenia, but not mortality, were elevated in patients with lupus receiving immune checkpoint inhibitor therapy for

CHICAGO — The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with moderate-to-severe plaque

SAN ANTONIO — Stories and analogies can help rheumatology patients understand the complexities of their conditions and improve medication adherence,

Helping patients with lupus navigate disability insurance, so they can maintain care after a job loss, is just one step